Close to 3 out of 4 women are ready to take steps-- within the next six months-- to demand more from their money. Yahoo Finance's Jeanie Ahn talks with Julie Hyman about how.
Pfizer (PFE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Pfizer stock remains under pressure despite becoming one of the biggest names of the pandemic. Is PFE stock a sell?
(Bloomberg) -- The Biden administration’s efforts to revitalize the chip industry have mostly focused on doling out multibillion-dollar grants for domestic factories. But there’s a less-discussed side to the push: turning cutting-edge semiconductor research into a more enticing field for Americans. Most Read from BloombergBiden’s Gains Against Trump Vanish on Deep Economic Pessimism, Poll ShowsTaylor Swift Is Proof That How We Critique Music Is BrokenZuckerberg Asks for Patience After Meta’s AI
High-yield dividend stocks continue to attract attention, promising both steady income and potential capital appreciation. As geopolitical tensions grapple economies worldwide, the stock market has been extremely volatile, as evidenced by the CBOE ...
Analysts are bullish on three well-known Dividend Aristocrats, forecasting upside potential as high as 25%. NextEra Energy Inc. (NYSE:NEE), Chevron Corp. (NYSE:CVX), and Exxon Mobil Corp. (NYSE:XOM) have all received recent positive analyst coverage ...
IBM stock slipped after the computing giant reported first quarter earnings ahead of expectations, with sales slightly below.
These stocks yield between 3.2% and 7.7% in dividends.
These two pharma stocks have followed distinct paths of late. Which is the better investment?
Ares Capital (ARCC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
AT&T Inc. (NYSE:T) reported fiscal first-quarter 2024 operating revenues of $30.03 billion, down 0.4% year over year and missing the consensus of $30.54 billion. Adjusted EPS of $0.55 beat the consensus of $0.54. The stock price gained after the print. The results reflected declines in Mobility equipment revenues, driven mainly by lower sales volumes and lower Business Wireline revenues. Also Read: Verizon’s Q1: Flat Revenue, Bump In Free Cash Flow And Stable 2024 Outlook In the Mobility segment